1. Home
  2. PLSE vs MRC Comparison

PLSE vs MRC Comparison

Compare PLSE & MRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLSE
  • MRC
  • Stock Information
  • Founded
  • PLSE 2014
  • MRC 1921
  • Country
  • PLSE United States
  • MRC United States
  • Employees
  • PLSE N/A
  • MRC N/A
  • Industry
  • PLSE Medical/Dental Instruments
  • MRC Industrial Machinery/Components
  • Sector
  • PLSE Health Care
  • MRC Industrials
  • Exchange
  • PLSE Nasdaq
  • MRC Nasdaq
  • Market Cap
  • PLSE 1.1B
  • MRC 1.1B
  • IPO Year
  • PLSE 2016
  • MRC 2012
  • Fundamental
  • Price
  • PLSE $15.25
  • MRC $13.73
  • Analyst Decision
  • PLSE Buy
  • MRC Strong Buy
  • Analyst Count
  • PLSE 1
  • MRC 3
  • Target Price
  • PLSE $22.00
  • MRC $15.67
  • AVG Volume (30 Days)
  • PLSE 188.3K
  • MRC 1.5M
  • Earning Date
  • PLSE 08-11-2025
  • MRC 08-06-2025
  • Dividend Yield
  • PLSE N/A
  • MRC N/A
  • EPS Growth
  • PLSE N/A
  • MRC N/A
  • EPS
  • PLSE N/A
  • MRC N/A
  • Revenue
  • PLSE N/A
  • MRC $2,946,000,000.00
  • Revenue This Year
  • PLSE N/A
  • MRC $5.01
  • Revenue Next Year
  • PLSE $700.00
  • MRC $4.81
  • P/E Ratio
  • PLSE N/A
  • MRC N/A
  • Revenue Growth
  • PLSE N/A
  • MRC N/A
  • 52 Week Low
  • PLSE $13.50
  • MRC $9.23
  • 52 Week High
  • PLSE $25.00
  • MRC $15.59
  • Technical
  • Relative Strength Index (RSI)
  • PLSE 51.51
  • MRC 53.57
  • Support Level
  • PLSE $15.50
  • MRC $12.39
  • Resistance Level
  • PLSE $17.27
  • MRC $13.54
  • Average True Range (ATR)
  • PLSE 0.75
  • MRC 0.53
  • MACD
  • PLSE 0.16
  • MRC -0.06
  • Stochastic Oscillator
  • PLSE 55.41
  • MRC 29.22

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

About MRC MRC Global Inc.

MRC Global Inc distributes pipes, valves, fittings, and other infrastructure products and services to diversified gas utility, energy, and industrial end-markets. It provides supply chain solutions, technical product service and a digital platform for customers globally. It offers a range of PVF, oilfield supply, valve automation and modification, measurement, instrumentation, and other general and specialty products. Its geographical segments include the United States and International. It generates the majority of its revenue from the United States.

Share on Social Networks: